REGEN – D 150
Recombinant Human Epidermal Growth Factor (rh-EGF) Gel
pack size : 7.5 & 15 gms
- 150 mcg/g rh-EGF
- Indicated for Diabetic Foot Ulcers
- Promotes Angiogenesis & Granulation
- Supports Faster Wound Closure
Product USPs
High-Potency Regenerative Action
Reduces Risk of Amputation in DFU
Proven efficacy and safety with clinical studies
Accelerates Epithelial Tissue Repair
Product Indications
REGEN-D Promotes Epidermal Regeneration And Enhance Tissue Repair In Acute And Chronic Wounds, Including Diabetic Ulcers And Surgical Wounds.
Diabetic Foot Ulcers
Supports granulation tissue formation and promotes tissue regeneration in chronic diabetic wounds, facilitating progression toward closure.
Pressure Sores
Promotes tissue repair in pressure-induced skin injuries by supporting cellular regeneration and maintaining a conducive healing environment.
Venous Ulcers
Enhances wound healing in ulcers associated with venous insufficiency by supporting tissue regeneration and improving wound bed conditions.
Surgical Wounds
Supports post-operative healing by promoting tissue regeneration and facilitating the natural repair process.
CLINICAL STUDIES
Scientifically Proven. Clinically Trusted.
Enhanced Tissue Regeneration in Traumatic Injury
Use of Collagen Matrix provided structural scaffold support, promoting granulation tissue formation and wound closure within 12 days.
READ MORE >
Effective Management of Superficial to Partial-Thickness Thermal Burn
Topical SLVRGEN facilitated burn wound stabilization and progressive healing over a 16-day treatment period
READ MORE >
Accelerated Tissue Regeneration in Post-Amputation Wound
REGEN-D 150 promoted rapid granulation and progressive epithelialization, resulting in full wound closure within 8 weeks.
READ MORE >